FOR IMMEDIATE RELEASE TheraPsil Welcomes Dr. Ingrid Pacey as Clinical Director to Expand Psychedelic Therapy Training Programs VANCOUVER, BC, June 27, 2024 – TheraPsil is pleased to announce that Dr. Ingrid Pacey has been named its new Clinical Director, where she will oversee all of TheraPsil’s training programs. With a rich history in … Read more
FOR IMMEDIATE RELEASE First Canadian Patient with Cluster Headaches Granted Psilocybin Access by Health Canada Historic decision marks a new chapter in compassionate healthcare June 12, 2024 – Ottawa, ON – Health Canada has taken a historic step by granting emergency access to psilocybin for Jody Lance, a Calgary man suffering from debilitating … Read more
FOR IMMEDIATE RELEASE Breakthrough for Medical Psilocybin: Court Overturns Health Canada Decision Federal Court Deems Health Canada’s Decision “Unreasonable” and “Lacking Intelligibility” Ottawa, Ontario, May 24, 2024 – TheraPsil, a non-profit coalition dedicated to helping Canadians in medical need access legal psychedelic therapy, is celebrating a significant landmark decision by the Federal Court of … Read more
FOR IMMEDIATE RELEASE Quebec Breaks New Ground in Psychedelic Therapy: Patients Treated Together at Hope & Cope Cancer Wellness Centre MONTRÉAL, QC, November 13th, 2023 – In a historic development, two cancer patients received simultaneous psilocybin-assisted therapy (PAT) treatment on September 22nd, 2023, at The Hope & Cope Wellness Centre in Montréal, under the care of … Read more
FOR IMMEDIATE RELEASE TheraPsil Unveils MDMA-Assisted Psychotherapy Training Program VANCOUVER, BC, September 25th, 2023 – TheraPsil, an non-profit organization dedicated to advancing legal access to psychedelic-assisted psychotherapy in Canada, is pleased to announce its latest endeavour, which has just received Board approval: an MDMA-Assisted Psychotherapy Training Program. With over 500 healthcare professionals trained in … Read more
VANCOUVER, BC, May 9th, 2023, Lucy Scientific, a clinical-stage natural and synthetic psychedelic drug development company, has officially announced its participation in TheraPsil’s Project Solace, the world’s largest medical psilocybin access and data project. Project Solace is a TheraPsil-led research project that aims to expand legal access to psilocybin for Canadian patients suffering from end-of-life … Read more
Dear Ministers Jean Yves Duclos and Minister Carolyn Bennett, I am writing on behalf of TheraPsil, a non-profit organization that advocates for access to psilocybin-assisted psychotherapy for Canadians in medical need. We urge you to reconsider the recent decisions to revoke Section 56 exemptions for Janis Hughes and Thomas Hartle, two terminally ill Canadians who … Read more
Vancouver, BC – TheraPsil, a non-profit and training organization dedicated to legalizing access to psilocybin therapy for patients in medical need, expresses grave concern over recent allegations of Health Minister Jean-Yves Duclos interfering with the work of the Patented Medicine Prices Review Board (PMPRB), which has been engaged in a multi-year effort to implement changes … Read more
(Montreal, QC – April 13th, 2023) – TheraPsil, a non-profit organization dedicated to promoting legal access to psilocybin-assisted psychotherapy in Canada, is pleased to announce its very first bilingual training cohort for the Fundamentals of Psilocybin Assisted Psychotherapy program. This training program is designed to provide participants with the necessary knowledge and skills to offer … Read more
TheraPsil Applauds Healthcare Funding to B.C. From Federal Government VANCOUVER, BC (March 6th, 2023) – TheraPsil, a Vancouver-based non-profit and training organization advocating for legal access to psilocybin for those in medical need, welcomes the recent healthcare funding agreement between the British Columbia (B.C.) government and the federal government. TheraPsil is thrilled to be … Read more
